Euro Surveill. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020

[tetano]

Euro Surveill. 2020 Feb;25(8). doi: 10.2807/1560-7917.ES.2020.25.8.2000170. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020.

Bordi L¹, Nicastri E¹, Scorzolini L¹, Di Caro A¹, Capobianchi MR¹, Castilletti C¹, Lalle E¹, On Behalf Of Inmi Covid-Study Group And Collaborating Centers^2,1.
Author information

Abstract

A novel coronavirus (SARS-CoV-2) has been identified as the causative pathogen of an ongoing outbreak of respiratory disease, now named COVID-19. Most cases and sustained transmission occurred in China, but travel-associated cases have been reported in other countries, including Europe and Italy. Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.


KEYWORDS:

SARS-CoV-2; differential diagnosis; rapid molecular assay; respiratory pathogens

PMID: 32127123 DOI: 10.2807/1560-7917.ES.2020.25.8.2000170
Free full text